Gadofosveset-enhanced MRI for the assessment of rectal cancer lymph nodes: predictive criteria

PurposeTo confirm the use of the nodal signal intensity (SI) and the ‘chemical shift’ artefact as diagnostic criteria for detecting nodal metastases from rectal cancer on gadofosveset contrast-enhanced MRI.MethodsThirty-three patients underwent a non-enhanced and gadofosveset-enhanced 3D-T1W GRE-MRI at 1.5T. For each lymph node, the SI of the middle part of the node (mSI) and white rim of the chemical shift artefact encircling the node (wSI) were measured on the non-enhanced and gadofosveset-enhanced images. Second, the aspect of the chemical shift artefact encircling the nodes was scored using a 4-point scale. Results were compared with histology on a node-by-node basis.Results289 nodes (55 N+) were analysed. On gadofosveset-MRI, mSI and wSI were significantly higher for the benign than for the metastatic lymph nodes (p < 0.001). Areas under the ROC curve (AUC) for identification of metastases were 0.74 (mSI) and 0.73 (wSI). The chemical shift criterion rendered an AUC of 0.85. The combination of mSI and the chemical shift criterion resulted in an AUC of 0.88 and the rendered an AUC of 0.86–0.92 when subjectively (visually) assessed by two independent readers.ConclusionsBenign lymph nodes show significant contrast enhancement after gadofosveset injection, while metastatic nodes do not. The uptake of gadofosveset in the nodes also affects the chemical shift artefact encircling the nodes. Combined assessment of these two features on gadofosveset-enhanced MRI provides a high diagnostic performance for diagnosing metastatic lymph nodes in patients with rectal cancer.

[1]  T. Leiner,et al.  Gadovosfeset Trisodium (Vasovist ® ) Enhanced MR Lymph Node Detection: Initial Observations , 2009 .

[2]  A. Darzi,et al.  Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. , 2006, The Lancet. Oncology.

[3]  T. Takahara,et al.  Diffusion magnetic resonance imaging with gadofosveset trisodium as a negative contrast agent for lymph node metastases assessment , 2011, Japanese Journal of Radiology.

[4]  J. V. van Engelshoven,et al.  Imaging for predicting the risk factors--the circumferential resection margin and nodal disease--of local recurrence in rectal cancer: a meta-analysis. , 2005, Seminars in ultrasound, CT, and MR.

[5]  B. Misselwitz.  MR contrast agents in lymph node imaging. , 2006, European journal of radiology.

[6]  J. V. van Engelshoven,et al.  USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria. , 2008, Radiology.

[7]  Rieken,et al.  [Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer]. , 2001, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[8]  D. Koh,et al.  Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings--initial observations. , 2004, Radiology.

[9]  Patrick M M Bossuyt,et al.  Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis. , 2004, Radiology.

[10]  M. Guerrieri,et al.  A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy , 2007, Surgical Endoscopy.

[11]  Zongguang Zhou,et al.  Patterns of neoplastic foci and lymph node micrometastasis within the mesorectum , 2005, Langenbeck's Archives of Surgery.

[12]  I. Nagtegaal,et al.  No downstaging after short-term preoperative radiotherapy in rectal cancer patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  A. E. Canda,et al.  Wait-and-See Policy for Clinical Complete Responders After Chemoradiation for Rectal Cancer , 2011 .

[14]  T. Leiner,et al.  Accuracy of Gadofosveset-enhanced MRI for Nodal Staging and Restaging in Rectal Cancer , 2011, Annals of surgery.

[15]  T. Junginger,et al.  Neoadjuvant Chemoradiation and Local Excision for T2-3 Rectal Cancer , 2008, Annals of Surgical Oncology.

[16]  J. Gama-Rodrigues,et al.  Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy , 2006, Journal of Gastrointestinal Surgery.

[17]  A. Herlihy,et al.  Diagonal-SPRITE and Its Applications for In Vivo Imaging at High Field , 2009 .

[18]  J. Debatin,et al.  Interstitial MR lymphography with MS-325: characterization of normal and tumor-invaded lymph nodes in a rabbit model. , 2002, AJR. American journal of roentgenology.